Peregrine Pharmaceuticals reported $1.57B in Market Capitalization for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Acceleron Pharma XLRN:US $ 7.62B 606.02M
Adamas Pharmaceuticals ADMS:US 239.75M 41.19M
Agenus AGEN:US $ 1.22B 664.46M
Amgen AMGN:US $ 140.05B 3.22B
AstraZeneca AZN:LN 113.99B 18.86B
Biocryst Pharmaceuticals BCRX:US $ 2.81B 1B
Bristol Myers Squibb BMY:US $ 148.48B 7.52B
Celldex Therapeutics CLDX:US $ 1.32B 508.65M
Chemocentryx CCXI:US $ 933.95M 2.64B
Dicerna Pharmaceuticals DRNA:US $ 2.87B 918.39M
Eli Lilly And LLY:US $ 220.12B 40.96B
Flexion Therapeutics FLXN:US $ 411.02M 35.8M
GlaxoSmithKline GSK:LN 71.42B 6.62B
Immunogen IMGN:US $ 1.32B 300.21M
Intrexon XON:US $ 1.35B 76.37M
Karyopharm Therapeutics KPTI:US $ 774.96M 14.69M
Kindred Biosciences KIN:US $ 415.16M 192.96M
Macrogenics MGNX:US $ 1.62B 176.65M
Mannkind MNKD:US $ 1.36B 384.05M
Merk MRK:US $ 196918.18M 1780.24M
Minerva Neurosciences NERV:US $ 99.11M 25.63M
Newlink Genetics NLNK:US $ 83.57M 13.91M
Novartis NOVN:VX 208.02B 8.76B
Novavax NVAX:US $ 15.73B 2.34B
Peregrine Pharmaceuticals PPHM:US $ 1.57B 458.25M
Repligen RGEN:US $ 10.96B 311.93M
Xencor XNCR:US $ 2.01B 489.02M